GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyper Corporation Inc (XKRX:065650) » Definitions » Cash Flow from Others

Hyper (XKRX:065650) Cash Flow from Others : ₩10,950 Mil (TTM As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Hyper Cash Flow from Others?

Hyper's cash flow from others for the three months ended in Mar. 2024 was ₩9,078 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2024 was ₩10,950 Mil.


Hyper Cash Flow from Others Historical Data

The historical data trend for Hyper's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyper Cash Flow from Others Chart

Hyper Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only 79.76 1,197.62 7,779.11 8,380.18 2,091.79

Hyper Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 219.98 10,285.89 195.93 -8,610.02 9,078.45

Hyper Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩10,950 Mil.

Hyper Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Hyper's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyper (XKRX:065650) Business Description

Traded in Other Exchanges
N/A
Address
Woolim A-1401, 583, Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07547
Medifron DBT Co Ltd is a Korean clinical stage biopharmaceutical company. The company is focused on the development of Alzheimer's disease (AD) and neuropathic pain (NP) treatment and AD diagnostics.

Hyper (XKRX:065650) Headlines

No Headlines